Related Experiment Videos
A casein variant in cow's milk is atherogenic
Kristy A Tailford1, Celia L Berry, Anita C Thomas
1Centre for Research in Vascular Biology, School of Biomedical Sciences, University of Queensland, Brisbane, Qld 4072, Australia.
Atherosclerosis
|September 6, 2003
Summary
Beta-casein A1 consumption significantly increased atherosclerosis markers in rabbits compared to beta-casein A2. This study indicates beta-casein A1 is atherogenic, while beta-casein A2 is not.
Area of Science:
- Cardiovascular Research
- Nutritional Science
- Protein Biochemistry
Background:
- Cow's milk contains casein protein variants, notably beta-casein A1 and beta-casein A2.
- Epidemiological studies suggest a link between beta-casein consumption and atherosclerosis development.
Purpose of the Study:
- To investigate the direct impact of beta-casein A1 versus beta-casein A2 on atherosclerosis progression in a rabbit model.
Main Methods:
- Sixty rabbits underwent carotid artery de-endothelialization and were randomly assigned to diets with varying casein isolates (A1 or A2) or whey, with or without cholesterol supplementation.
- Blood lipid profiles and atherosclerotic lesion development in the aorta and carotid arteries were assessed over six weeks.
Main Results:
- In the absence of dietary cholesterol, beta-casein A1 significantly elevated serum cholesterol, LDL, HDL, and triglyceride levels compared to beta-casein A2.
- Rabbits fed beta-casein A1 exhibited significantly greater aortic fatty streak coverage and lesion thickness than those fed beta-casein A2.
- Dietary cholesterol exacerbated lesion thickness in beta-casein A1-fed rabbits compared to A2 counterparts.
Conclusions:
- Beta-casein A1 demonstrates atherogenic properties, promoting atherosclerosis development and lipid profile changes.
- Beta-casein A2 consumption did not show similar atherogenic effects, suggesting a safer profile.
- These findings highlight the differential impact of beta-casein variants on cardiovascular health.